Related News:
- New data for Roche’s Evrysdi (risdiplam) demonstrate…
- New three-year data for Roche’s Evrysdi (risdiplam)…
- Roche’s Evrysdi (risdiplam) granted FDA priority…
- Roche’s Evrysdi (risdiplam) granted FDA priority…
- FDA approves Roche’s Evrysdi for use in babies under…
- Roche to present new Evrysdi data at MDA 2022 and…